The title compounds were prepared as described previously (M = Mo, X = Cl) or by the reaction of the known unsaturated complex [W2Cp2(μ-PtBu2)(CO)4]BF4 with NaI in refluxing 1,2-dichloroethane solution. Reaction of these halide-bridged complexes with NO (1 atm) at low temperature yielded the corresponding dinitrosyl derivatives syn,trans-[M2Cp2X(μ-PtBu2)(CO)(NO)2], with a syn arrangement of Cp ligands relative to the M2P plane, and a transoid arrangement of the halide ligand X relative to the P atom, according to an X-ray study on the ditungsten complex (W−W = 3.113(1) Å). Further decarbonylation of these products at high temperature yielded in both cases the halide-bridged complexes trans-[M2Cp2(μ-X)(μ-PtBu2)(NO)2] as major products, but the minor products were different. For the molybdenum complex, an isomer of the final product, cis-[Mo2Cp2(μ-Cl)(μ-PtBu2)(NO)2], was formed. In contrast, the minor tungsten product, anti,cis-[W2Cp2I(μ-PtBu2)(CO)(NO)2], was an isomer of the parent complex. In addition, trace amounts of the imide cyclopentadienylidene complex [W2Cp(μ-κ:η5-C5H4)I(μ-PtBu2)(NH)(NO)] was also obtained (W−W = 2.9376(2) Å). Density functional theory calculations were used to examine possible routes to the above dinitrosyl complexes, that seem to involve at least three reaction pathways: direct decarbonylation, rearrangement of the MCpX(NO) fragment prior to decarbonylation, and rearrangement of the MCp(CO)(NO) fragment prior to decarbonylation.
No takes yet. Share an insight, caveat, or question.
Alvarez et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: